• Synthorx Reports Third Quarter Financial Results

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 05, 2019 - Synthorx, Inc. , a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results and provided a business update......
    Read more ...